| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |